June 1Â (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Monday that its consolidated net profit, excluding minority interest, fell to 10.8Â million levs ($6.1Â million/5.5Â million euro) in the first quarter of 2020 from 15.4Â million levs in the same period of last year, hurt by higher cost of goods sold.